Mass spectrometry in neonatal medicine and clinical diagnosis--the [corrected] potential use of mass spectrometry in neonatal brain [corrected] monitoring.
This article discusses the application of mass spectroscopy, a technology that may have great potential for screening neonatal brain injury. This approach is anticipated to become increasingly important in neonatal and perinatal research and newborn care during the next few years.
Spitzer
Alan R
AR
Pediatrix Medical Group, 1301 Concord Terrace, Sunrise, FL 33323, USA. Alan_Spitzer@pediatrix.com
Chace
Donald
D
D001921:Brain / Q000378:metabolism / Q000502:physiology*; D001927:Brain Diseases / Q000175:diagnosis / Q000209:etiology; D001928:Brain Diseases, Metabolic / Q000175:diagnosis; D023281:Genomics; D006801:Humans; D007231:Infant, Newborn; D013058:Mass Spectrometry / Q000379:methods*; D008991:Monitoring, Physiologic / Q000379:methods*; D015997:Neonatal Screening; D009359:Neonatology; D040901:Proteomics